ABSTRACT
End-stage renal disease (ESRD) requires for its treatment permanent dialysis or kidney transplantation (KT). KT is the best clinical treatment, however, the early function of the allograft varies depending on multiple factors associated with cold ischemia time (CIT) and the allograft rejection process. It is known that serum creatinine is an insensitive and late marker for predicting graft recovery after KT, mainly in patients with delayed graft function (DGF). Neutrophil gelatinase-associated lipocalin (NGAL) is produced in the distal nephron and it is one of the most promising novel biomarkers for acute kidney injury (AKI) and chronic kidney disease (CKD). NGAL has been proposed to be a predictor of organ recovery from DGF after KT from donors after cardiac death. Because nonrenal diseases can also induce NGAL, more information is necessary to validate the sensitivity and specificity of urine and plasma NGAL in clinical samples. The exosomes are vesicles released into the urine from the kidney epithelium and they have been proposed as better source to explore as biomarker of renal dysfunction. The molecular composition of the urinary exosomes could be representative of the physiological or physiopathologic condition of the urinary system. We propose that determination of NGAL in urinary exosomes is a better predictor of kidney dysfunction after KT than other urinary fractions. We analyzed 15 kidney allograft recipients, with a mean age of 36 years (range, 16-60 years) and 75% were male: 11 living donors (LD) and 4 deceased donors (DD). The average length of CIT was 14 hours in DD and less than 1 hour in LD. Three patient developed DGF. Using Western blot analysis, NGAL was detectable in the cellular and exosomal fraction of the urine. The exosomes expressed higher levels of NGAL than the cellular fraction. The expression of NGAL was observed from the first day after transplantation. In the cellular fraction of the urine, no significant differences of NGAL were observed between the patients. However, the median of NGAL expression in the exosomes fraction was significantly higher in DD patient, from the first day after KT (P < .05). Moreover, we noticed that NGAL expression in exosomes remained elevated in the patients with DGF compared with non-DGF patients (P < .05). Considering the highest abundance of NGAL in the urinary exosomes and its correlation with DGF patients, we suggest the exosomal fraction as a more sensitive substrate to evaluate early biomarkers of DGF after KT.
Subject(s)
Acute-Phase Proteins/urine , Delayed Graft Function/etiology , Exosomes/enzymology , Kidney Failure, Chronic/surgery , Kidney Transplantation/adverse effects , Kidney/enzymology , Kidney/surgery , Lipocalins/urine , Proto-Oncogene Proteins/urine , Adolescent , Adult , Biomarkers/urine , Blotting, Western , Cadaver , Delayed Graft Function/diagnosis , Delayed Graft Function/enzymology , Delayed Graft Function/physiopathology , Delayed Graft Function/urine , Female , Humans , Kidney/physiopathology , Lipocalin-2 , Living Donors , Male , Middle Aged , Predictive Value of Tests , Time Factors , Treatment Outcome , Up-Regulation , Young AdultABSTRACT
Peutz-Jeghers syndrome (PJS) is an autosomal dominant disorder characterized by mucocutaneous melanocytic macules, gastrointestinal hamartomatous polyposis and an increased risk of various neoplasms. Germline mutations in the serine/threonine kinase 11 (STK11) gene have been identified as a cause for PJS. The aim of this study was to characterize the genotype of Chilean PJS patients. Mutation screening of 13 patients from eight PJS families was performed using a single strand conformation polymorphism analysis, DNA sequencing and multiplex ligation-dependent probe amplification assay. The breakpoints of the genomic rearrangements were assessed by a long-range polymerase chain reaction and sequencing. The results revealed the existence of seven different pathogenic mutations in STK11 gene in seven unrelated families, including three point mutations and four large genomic deletions. Three of these point mutations (43%, 3/7) may be considered as novel. Our results showed that a germline mutation is present in STK11 in 88% of probands fulfilling the diagnostic criteria of PJS. In this study, the combination of two different experimental approaches in the screening of the STK11 in PJS, led to a higher percentage of mutation detection.
Subject(s)
Germ-Line Mutation , Peutz-Jeghers Syndrome/genetics , Point Mutation , Protein Serine-Threonine Kinases/genetics , RNA Splicing/genetics , AMP-Activated Protein Kinase Kinases , Adolescent , Adult , Child , Child, Preschool , Female , Genotype , Humans , Infant , Male , Multiplex Polymerase Chain Reaction/methodsABSTRACT
The control of viral infections, mainly those caused by influenza viruses, is of great interest in Public Health. Several studies have shown the presence of active properties in the hemolymph of arthropods, some of which are of interest for the development of new pharmacological drugs. Recently, we have demonstrated the existence of a potent antiviral property in the hemolymph of Lonomia obliqua caterpillars. The aim of this study was to produce an antiviral protein in a baculovirus/Sf9 cell system. The resulting bacmid contains the sequence coding for the antiviral protein previously described by our group. Total RNA from L. obliqua caterpillars was extracted with Trizol and used in the reverse transcription assay with oligo(d)T primer followed by polymerase chain reactions (RT-PCR) with specific primers for the cDNA coding for the antiviral protein, based on the sequence deposited in the GenBank database. Restriction sites were inserted in the cDNA for ligation in the donor plasmid pFastBac1™. The recombinant plasmid was selected in Escherichia coli DH5α and subsequently used in the transformation of E. coli DH10Bac for the construction of the recombinant bacmid. This bacmid was used for the expression of the antiviral protein in the baculovirus/Sf9 cell system. After identifying the protein by western blot, activity tests were performed, showing that the purified recombinant protein was able to significantly reduce viral replication (about 4 logs). Studies on the optimization of the expression system for the production of this antiviral protein in insect cells are in progress.
Subject(s)
Antiviral Agents/pharmacology , Biological Products/pharmacology , Hemolymph/chemistry , Hemolymph/immunology , Insect Proteins/biosynthesis , Insect Proteins/pharmacology , Lepidoptera/immunology , Animals , Antiviral Agents/isolation & purification , Baculoviridae/genetics , Biological Products/isolation & purification , Cell Line , Cloning, Molecular , Escherichia coli/genetics , Gene Expression , Genetic Vectors , Insect Proteins/genetics , Lepidoptera/genetics , Recombinant Proteins/genetics , Recombinant Proteins/pharmacologyABSTRACT
Se analiza un brote de gastroenteritis por shigella sonnei, ocurrido en una escuela básica de una comuna de Santiago, en marzo de 1997. En esta escuela, con una matricula de 1470 niños entre 5 y 14 años de edad, 350 se beneficiaban con el programa de alimentación escolar (pae) y almorzaban en el establecimiento. Treinta y cinco de los 350 niños del pae presentaron simultáneamente gastroenteritis que motivó consulta en un servicio de emergencia, 2 de los cuales presentaron diarrea con sangre requiriendo hospitalización. Durante los cinco días posteriores se registraron 189 nuevos casos en la escuela. Frente a la notificación, se efectuó visita epidemiológica a la escuela, obteniéndose muestras de deposición para estudio de bacterias y virus enteropatógenos en 65 niños sintomáticos y en los tres manipuladores de alimentos. Se identificó s. sonnei en 20,5 porciento de los coprocultivos y todas las cepas tenían el mismo antibiotipo. La búsqueda de virus entéricos (rotavirus, calcivirus) dio resultados negativos. En los manipuladores de alimentos no se detectó enteropatógenos bacterianos ni virales. La presentación del brote plantea una toxiinfección por s. sonnei, iniciada probablemente por ingestión de alimentos (tasa de ataque primario 10 porciento) y luego transmisión persona a persona (tasa de ataque secundario 16,9 porciento) Para controlar el brote se reforzaron medidas de higiene personal y de saneamiento ambiental a través de educación a toda la comunidad escolar y el control sanitario del establecimiento. A partir del quinto día de iniciado el primer caso, se administró cotrimoxazol, durante cinco días, sólo a los casos sintomáticos. El brote se controló al noveno día